Home

The Latest Stories

Senate bill to encourage generic drug market

WASHINGTON (Reuters) - Generic drugs would have an easier path to U.S. markets under a bill due to be introduced in the Senate, said Democratic Senator Jeff Bingaman, a sponsor of the bill.

The bill also has the support of Republican Senator David Vitter and will be introduced on Wednesday, Bingaman's office said.

It would amend the 1984 Hatch-Waxman ...

Arrests mark U.S. prescription drug abuse crackdown

TAMPA, Florida (Reuters) - U.S. authorities arrested 22 people in Florida on Friday, including pharmacists and doctors, in a crackdown against prescription drug abuse that officials say is the nation's fastest growing drug problem.

The arrests in Orlando and Tampa were the latest steps in successive operations by federal and local authorities to shut down so-called "pill mill" pain ...

US lawmakers reject Canada drug purchases

The US Senate Thursday rejected a measure that would have enabled Americans to buy prescription drugs in Canada in a bid to reduce the costs of their health care.

The measure, an amendment to a spending bill, was defeated by a vote of 45 to 55.

It would have barred the US Food and Drug Administration from spending money to ...

Lower Drug Costs in the Doughnut Hole

The coverage gap in the Part D prescription-drug plan has started closing through a combination of government subsidies and drug-company discounts.

The coverage gap in the Part D prescription-drug plan has started closing through a combination of government subsidies and drug-company discounts.

EDITOR'S NOTE: This article, which was originally published in the February 2011 issue of Kiplinger's Retirement ...

Lobbyists circle drug makers over deficit talks

WASHINGTON (Reuters) - With pressure mounting for a deficit-reduction deal in Congress, the $300 billion pharmaceutical industry is looking a little like a ship at sea with danger in the water below.

Drug makers have begun to emerge as a favorite target for cost-cutting proposals from others in the healthcare sphere who hope to avoid the fiscal knife themselves, lobbyists and ...

Google to settle drug probe for $500 million

Google will pay $500 million to settle charges that it sold advertisements to Canada-based online pharmacies which marketed drugs to Americans in violation of US law, US justice officials announced Wednesday.

The pharmacies broke the law by selling prescription drugs to Americans without complying with US safety standards, the US Department of Justice said in a statement.

"We banned ...

Google to pay $500 million over online drug ads

WASHINGTON (Reuters) - Google has agreed to pay $500 million to settle a probe that it allowed online Canadian pharmacies to place ads to sell drugs in the United States, the U.S. Justice Department said on Wednesday.

The forfeiture is one of the largest ever in the United States, the Justice Department said. It represents Google's revenues from Canadian ...

Agents dismantle alleged pill mills that netted $40 million

MIAMI (Reuters) - State and federal agents cracked down on Tuesday on South Florida pill mills, dismantling what was described as the nation's largest criminal organization involved in illegally distributing painkillers.

Authorities charged 32 doctors, pain clinic owners and workers with illegally prescribing more than 20 million painkillers and reaping more than $40 million in profits from 2008 to early ...

FDA, industry reach generic drug fee agreement

WASHINGTON (Reuters) - U.S. regulators and generic drugmakers have reached a compromise agreement for a user-fee program that would require the companies to pay some $299 million in the first year to accelerate drug approvals.

The Food and Drug Administration has been in negotiations with the generic drug industry since February to establish a user-fee program similar to one in ...

Hospital spending down after Medicare drug coverage

NEW YORK (Reuters Health) - After Medicare began covering prescription drugs in 2006, spending on hospital and nursing home stays appears to have dropped for seniors who had limited prior coverage.

That's the conclusion of a new report that hints Medicare Part D may have saved money by making it easier for chronically ill elderly people to manage their conditions ...

Previous